| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Bajaj Finserv Healthcare Fund Reg (G) |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
3.52 |
| Derivatives/Mutual Fund/ETF |
1.71 |
| Equity |
94.75 |
| Trep |
0.02 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
37.43% |
| Top 10 Holdings |
58.77% |
| Top 25 Holdings |
89.92% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
65.27 |
| Healthcare |
18.33 |
| Retail |
3.93 |
| Cash |
3.54 |
| Food Beverage & Tobacco |
2.46 |
| Chemicals |
2.05 |
| Consumer Durables |
1.72 |
| Debt MF |
1.71 |
| Miscellaneous |
0.99 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.34 |
| PE Ratio |
46.01 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
9.41 |
| DIVI LABORATORIES LTD |
8.95 |
| Apollo Hospitals Enterprise Limited |
6.75 |
| Aurobindo Pharma Limited |
6.63 |
| Piramal Pharma Limited |
5.69 |
| Torrent Pharmaceuticals Limited |
5.57 |
| Emcure Pharmaceuticals Limited |
4.35 |
| Max Healthcare Institute Limited |
4.06 |
| Rubicon Research Limited |
3.84 |
| Net Receivables / (Payables) |
3.52 |
| Neuland Laboratories Limited |
3.42 |
| Fortis Health Care Ltd |
3.18 |
| IPCA Laboratories Limited |
2.69 |
| EQ -ZYDUS WELLNESS LTD. |
2.46 |
| NAVIN FLUORINE INTERNATIONAL L |
2.05 |
| SANOFI CONSUMER HEALTHCARE |
1.98 |
| Glenmark Pharmaceuticals Limited |
1.97 |
| Glaxosmithkline Pharma Ltd |
1.81 |
| Vijaya Diagnostic Centre Limited |
1.77 |
| Shaily Engineering Plastics Limited |
1.72 |
| Bajaj Finserv Money Market Fund-Direct Plan-Growth |
1.71 |
| Laurus Labs Limited |
1.65 |
| Godrej Consumer Products Limited |
1.64 |
| Lupin Limited |
1.56 |
| Dr Lal Path Labs Ltd |
1.54 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
